Ovulation Induction

• 

  Subject Areas on Research

  • Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women. 
  • Altering hirsutism through ovulation induction in women with polycystic ovary syndrome. 
  • Analysis of ectopic pregnancies resulting from in-vitro fertilization and embryo transfer. 
  • Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. 
  • Combined impact of the number of pre-ovulatory oocytes and cryopreservation on IVF outcome. 
  • Comparison of low-technology and high-technology monitoring of clomiphene citrate ovulation induction. 
  • Delaying the initiation of progesterone supplementation results in decreased pregnancy rates after in vitro fertilization: a randomized, prospective study. 
  • Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance. 
  • Do not increase the burden for poor responders. 
  • Does progesterone supplementation improve pregnancy rates in clomiphene citrate and intrauterine insemination treatment cycles? 
  • Effectiveness of assisted reproductive technology (ART). 
  • Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. 
  • Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial. 
  • Experience with diethylstilbestrol-exposed infertile women in a program of in vitro fertilization. 
  • Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome. 
  • Fertilization and in vitro development of cryopreserved human prophase I oocytes. 
  • Fewer medications for in vitro fertilization can be better: thinking outside the box. 
  • Gonadotropin stimulation for in vitro fertilization and embryo transfer in insulin-dependent diabetics: follicular response, oocyte quality, embryo development, and follicular environment. 
  • Gonadotropin stimulation protocols in the Norfolk IVF program--1988. 
  • High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome. 
  • Human embryos derived from in vitro and in vivo matured oocytes: analysis for chromosomal abnormalities and nuclear morphology. 
  • Impact of different clinical variables on pregnancy outcome following embryo cryopreservation. 
  • In vitro fertilization and embryo transfer (IVF/ET): an established and successful therapy for endometriosis. 
  • Late ovarian hyperstimulation syndrome after controlled ovarian stimulation in a woman with systemic lupus erythematosus and lupus nephritis. 
  • Maternal adjustment, parenting and child behaviour in families of school-aged twins conceived after IVF and ovulation induction. 
  • Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited. 
  • Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist. 
  • Optimal stimulation protocols for in vitro fertilization. 
  • Ovarian stimulation for in vitro fertilization in low-responder patients using pulsatile intravenous follicle stimulating hormone. 
  • Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients. 
  • Predictors of pregnancy in women with polycystic ovary syndrome. 
  • Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology. 
  • Relationship between human chorionic gonadotropin serum levels and the risk of ovarian hyperstimulation syndrome. 
  • Results of in vitro fertilization attempts in patients with one or two ovaries. 
  • Sonographic appearance of the endometrium: the predictive value for the outcome of in-vitro fertilization in stimulated cycles. 
  • Stimulation protocols for patients with "atypical response". 
  • Successful fertilization and pregnancy outcome in in-vitro fertilization using cryopreserved/thawed spermatozoa from patients with malignant diseases. 
  • The Risk of Congenital Anomalies by Fertility Treatment Modality. 
  • The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization. 
  • The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. 
  • The function of the corpus luteum of pregnancy in ovulatory dysfunction and luteal phase deficiency. 
  • The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with and without leuprolide acetate. 
  • The value of in vitro fertilization for the treatment of unexplained infertility. 
  • Total follicle stimulating hormone dose is negatively correlated with live births in a donor/recipient model with fresh transfer: an analysis of 8,627 cycles from the Society for Assisted Reproductive Technology Registry. 
  • Treatment of low responders. 
  • Ultrasonographic appearance of the endometrium in natural and stimulated in-vitro fertilization cycles and its correlation with outcome. 
  • Use of gonadotrophin-releasing hormone agonists in controlled ovarian hyperstimulation for in vitro fertilization. 
  • Utility of fluoroimmunoassay in detecting luteinizing hormone surges in spontaneous and human menopausal gonadotropin-stimulated menstrual cycles. 
  • Vitamin D Status Relates to Reproductive Outcome in Women With Polycystic Ovary Syndrome: Secondary Analysis of a Multicenter Randomized Controlled Trial.